Haleon trades up after smaller than expected GSK sale
In a block trade, GSK sold 2.6% of its former joint venture with Pfizer
Unlock this article.
The content you are trying to view is exclusive to our subscribers.
To unlock this article:
The content you are trying to view is exclusive to our subscribers.
To unlock this article: